Hemorrhoids screening and treatment prior to LVAD: is it a necessity?

Hadi Skouri, Mohammed Shurrab, Jad Zahnan, Samer Deeba, Pierre Sfeir, Walid Gharzuddin, Saleem Haj-Yahia

Abstract readCase Reports

In one paragraph

Article in Journal of cardiothoracic surgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hadi SkouriDivision of Cardiology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

Mohammed ShurrabNational Heart, Lung & Transplant Institute, An-Najah National University Hospital, An-Najah National University, Nablus, West Bank, Palestine.

Jad ZahnanDivision of Cardiology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

Samer DeebaDepartment of Surgery, American University of Beirut Medical Center, Beirut, Lebanon.

Pierre SfeirDepartment of Surgery, American University of Beirut Medical Center, Beirut, Lebanon.

Walid GharzuddinDivision of Cardiology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

Saleem Haj-YahiaNational Heart, Lung & Transplant Institute, An-Najah National University Hospital, An-Najah National University, Nablus, West Bank, Palestine. hajsaleem@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Continuous-flow left ventricle assist devices (CF-LVADs) has become an essential modality in the management of stage D heart failure (HF) with significant improvement in survival and quality of life. Due to the durability of such devices and long term support complications such as bleeding and aortic insufficiency has emerged. Bleeding accounts for more than 20 % with the majority being from the gastrointestinal tract. The increase of bleeding tendency are mainly attributed to the loss of large von Willebrand's Factor (vWF) multimers due to shear stress with the chronic intake of anticoagulants. We are reporting two cases of patients with Stage D HF and history of hemorrhoids presenting for LVAD implantation. Many efforts that decrease bleeding related to CF-LVADs will be discussed with focus on hemorrhoids.

Indexed as

Fatal OutcomeGastrointestinal HemorrhageHeart-Assist DevicesHeart FailureHemorrhoidsHumansMaleMass ScreeningMiddle AgedPreoperative CareHemorrhoidsLVADScreening

Identifiers

PMID27067282

DOI10.1186/s13019-016-0441-z

PMCPMC4828895

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.